MD® Intimate Restore — National Press Syndication (August 2015)
MD® Intimate Restore — National Press Syndication
August 25, 2015 · 13 outlets · PR Newswire distribution
On August 25, 2015, La Canada Ventures, Inc. and Dr. Susan Lin, M.D. announced the development of MD® Intimate Restore — the first physician-formulated, hormone-free, drug-free feminine rejuvenation cream supported by a Brazilian dermatologist-supervised safety study (Medcin Instituto da Pele, Protocol EN16-0158-01).
The announcement was syndicated nationally by PR Newswire (Story ID SF79402) and picked up by 13 outlets across major U.S. broadcast affiliates, regional Business Journals, healthcare trade press, and pharmaceutical industry publications.
Clinical Foundation
Two independent studies support the launch — a 3-phase dermatologist-supervised safety study at Medcin Instituto da Pele (Brazil, Protocol EN16-0158-01, 55 screened / 54 completed / 0 cutaneous reactions) and a GVI Mexico consumer-acceptance study across three target populations (vaginal birth, C-section, menopause).
Broadcast Affiliates
Regional Business Journals
Healthcare & Pharmaceutical Trade Press
Related Pages
External links above point to live archives of the original PR Newswire syndication (August 25, 2015, Story ID SF79402). Some legacy URLs may have been retired by their original publishers; the canonical PR Newswire announcement remains the source of record. MD® and MD Intimate Restore® are federally registered trademarks of La Canada Ventures, Inc. Reviewed: May 2026.
